Posts

Showing posts with the label Cerebral (Fatal) Malaria - Pipeline Review

First report Published on Cerebral (Fatal) Malaria - Pipeline Review, H2 2016

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Cerebral (Fatal) Malaria - Pipeline Review, H2 2016, provides an overview of the Cerebral (Fatal) Malaria (Infectious Disease) pipeline landscape. Cerebral malaria is the most dangerous and life-threatening form of malaria that affects the brain. It is caused by plasmodium falciparum, a protozoan parasite. Plasmodium gets transmitted to human via infected mosquito bites.Symptoms include fever, head ache, muscle pain, low blood pressure, coma and convulsions. Treatment includes antimalarial, antiseizure and anti inflammatory medications. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Cerebral (Fatal) Malaria - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Cerebral (Fatal) Malaria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of ad...